Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1995-06-07
1997-12-09
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241931, 424197112, 4242821, 5361231, A61K 3909, A61K 39385, A61K 4500, C07H 100
Patent
active
056957688
ABSTRACT:
The invention provides compositions comprising an oligosaccharide of S. pneumoniae serotype 8 useful for stimulating an immune response to an antigen, methods of providing protective immunization against a bacterial pathogen using these compositions, methods of augmenting an immunogenic response to an antigen by administering these S. pneumoniae serotype 8 oligosaccharide compositions along with the antigen, and methods of making the immunostimulatory compositions described above.
REFERENCES:
patent: 4619828 (1986-10-01), Gordon
patent: 4644059 (1987-02-01), Gordon
patent: 4663160 (1987-05-01), Tsay et al.
patent: 4673574 (1987-06-01), Anderson
patent: 4695624 (1987-09-01), Marburg et al.
patent: 4711779 (1987-12-01), Porro et al.
patent: 4771127 (1988-09-01), Cryz et al.
patent: 4882317 (1989-11-01), Marburg et al.
patent: 5153312 (1992-10-01), Porro
Anderson, P., "Antibody Responses to Haemophilus influenzae Type b and Diphtheria Toxin Induced by Conjugates of Oligosaccharides of the Type b Capsule with the Nontoxic Protein CRM.sub.197 " Infect. Immun. 39: 233-238 (1983).
Anderson, P. et al., "Immunogens Consisting of Oligosaccharides from the Capsule of Haemophilus influenzae Type b Coupled to Diphtheria Toxoid or the Toxin Protein CRM.sub.197 " J. Clin. Invest. 76: 52-59 (1985).
Anderson, P. et al., "Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b" Journal of Pediatrics 107: 346-351 (1985).
Anderson, P. et al., "Vaccines Consisting of Periodate-Cleaved Oligosaccharides from the Capsule of Haemophilus influenzae Type b Coupled to a Protein Carrier: Structural and Temporal Requirements for Priming in the Human Infant" J. of Immunol. 137: 1181-1186 (1986).
Anderson, P. et al., "Effect of Oligosaccharide Chain Length, Exposed Terminal Group, and Hapten Loading on the Antibody Response of Human Adults and Infants to Vaccines Consisting of Haemophilus influenzae Type b Capsular Antigen Uniterminally Coupled to the Diphtheria Protein CRM.sub.197 " J. of Immunol. 142: 2464-2468 (1989).
Avery, O.T. et al., "Chemo-Immunological Studies on Conjugated Carbohydrate-Proteins" J.Exp. Med. 50: 533-550 (1929).
Barra, A. et al., "Characterization of the Serum Antibody Response Induced by Haemophilus influenzae Type b Tetanus Protein-Conjugate Vaccine in Infants Receiving a DTP-Combined Vaccine from 2 Months of Age" Vaccine 11: 1003-1006 (1993).
Bhattacharjee, A.K. et al., "Structural Determination of the Sialic Acid Polysaccharide Antigens of Neisseria meningitidis Serogroups B and C with Carbon 13 Nuclear Magnetic Resonance" Journal of Biological Chemistry 250(5): 1926-1932 (1975).
Bixler, G.S. et al., "The Cellular Basis of the Immune Response to Conjugate Vaccines" Contrib. Microbiol. Immunol., J.M. Cruse and R. E. Lewis, eds., 10:18-47 (1989).
Bolan, G. et al., "Pneumococcal Vaccine Efficacy in Selected Populations in the United States" Ann. Internal Med. 104(1): 1-6 (1986).
Borgono, J.M. et al., "Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants (40010)" Proc. Soc. Exp. Biol. Med. 157: 148-154 (1978).
Broome, C.V. et al., "Pneumococal Disease After Pneumococcal Vaccination" New Eng. J. Med. 303(10): 549-552 (1980).
Bruyn, G.A.W. et al., "Pneumococcal Polysaccharide Vaccines: Indications, Efficacy and Recommendations" Eur. J. Clin. Microbiol. Infect. Dis. 10: 897-910 (1991).
Chudwin, D.S. et al., "Correlation of Serum Opsonins with In Vitro Phagocytosis of Streptococcus pneumoniae" Infect. Immun. 50: 213-217 (1985).
Connelly, K.K. et al., "Vaccine-Preventable Respiratory Infections in Childhood" Seminars in Respiratory Infections 6(4): 204-216 (1991).
Cruse, J.M. et al., "Contemporary Trends in Conjugate Vaccine Development" Contrib. Microbiol. Immunol., J. M. Cruse and Re. E. Lewis, eds., 10: 1-10 (1989).
Eby, R. et al., "Pneumococcal Conjugate Vaccines" in Modern Approaches to New Vaccines Including Prevention of AIDS, E. Norby, F. Brown and C. Chanock (eds.) (1994).
Fattom, A. et al., "Serum Antibody in Adult Volunteers Elicited by Injection of Streptococcus pneumoniae Type 12F Polysaccharide Alone or Conjugated to Diphtheria Toxoid" Infect. Immun. 58(7): 2309-2312 (1990).
Fattom, A. et al., "Synthesis and Physicochemical and Immunological Characterization of Pneumococcus Type 12F Polysaccharide-Diphtheria Toxoid Conjugates" Infect. Immun. 56(9): 2292-2298 (1988).
Forrester, H.L. et al., "Inefficacy of Pneumococcal Vaccine in a High-Risk Population" Am. J. Med. 83: 425-430 (1987).
Garner, C.V. et al., "Immunologic Considerations for the Development of Conjugate Vaccines" Contrib. Microbiol. Immunol. J. M. Cruse and R. E. Lewis, eds. 10: 11-17 (1989).
Gaur, A. et al., "Bypass by an Alternate `Carrier` of Acquired Unresponsiveness to hCG Upon Repeated Immunization with Tetanus-Conjugated Vaccine" Int. Immunol. 2(2): 151-155 (1990).
Giebink, G. S. et al., "Pneumococcal Capsular Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccines: Immunogenicity and Efficacy in Experimental Pneumococcal Otitis Media" J. Inf. Dis. 167: 347-355 (1993).
Goebel, W. F. et al., "Chemo-Immunological Studies on Conjugated Carbohydrate-Proteins" J. Exp. Med. 50: 521-531 (1929).
Hakamori, S. et al. "Carbohydrate Antigens in Higher Animals" Handbook of Experimental Immunology 1(Ch. 9): 9.1-9.39 (1986).
Hazlewood, M. et al., "The Acquisition of Anti-Pneumococcal Capsular Polysaccharide Haemophilus influenzae Type b and Tetanus Toxoid Antibodies,with Age, in the UK" Clin. Exp. Immunol. 93: 157-164 (1993).
Heidelberger, M. et al., "The Soluble Specific Substance of Pneumococcus" J. Exp. Med. 38: 73-79 (1929).
Hilleman, M. R. et al., "Streptococcus pneumoniae Polysaccharide Vaccine: Age and Dose Responses, Safety, Persistance of Antibody, Revaccination, and Simultaneous Administration of Pneumococcal and Influenza Vaccines" Reviews of Infectious Diseases 3(Suppl.): S31-S42 (1981).
Jennings, H. J. et al., "Structural Determination of the Capsular Polysaccharide of Streptococcus pneumoniae Type-19 (19F)" Can. J. Chem 58: 1069-1074 (1980).
Jennings, H. J. et al., "Structure of the Complex Polysaccharide C-Substances from Streptococcus pneumoniae Type 1" Biochemistry 19: 4712-4719 (1980).
Jones, J.K.N. et al., "The Structure of the Type VIII Pneumococcus Specific Polysaccharide" J. Am. Chem. Soc. 79: 2787-2793 (1957).
Kabat, E. A., "Carbohydrates as Antigens and Immunogens: Size, Shape and Nature of Carbohydrate Epitopes and Idiotopes Polysaccharide Vaccines" R. Bell and G. Torrigiani (eds., ) Towards Better Carbohydrate Vaccines, pp. 75-79 (1987).
Kenne, L. et al., "Bacterial Polysaccharides" The Polysaccharides, vol. 2, G. O. Aspinall, Ed., Academic Press, pp. 287-362 (1983).
Kenne, L. et al., "Structural Studies of the Capsular Antigen From Streptococcus pneumoniae Type 26" Carbohydrate Research 73: 175-182 (1979).
Klein, David L., "Pneumococcal Conjugate Vaccines: Review and Update" Microbial Drug Resistance 1(1): 49-58 (1995).
Klein, J. O., "Otitis Externa, Otitis Media, Mastoiditis," Mandell, G.L. et al.(eds.) Principles and Practice of Infectious Diseases, Churchill Livingston, Inc., New York, Ch. 43: 579-585 (1995).
Klugman, K.P. et al., "Antibiotic-Resistant Pneumococci in Pediatric Disease" Microbial Drug Resistance 1(1): 5-8 (1995).
Lee, C-J. et al., "Virulence, Immunity, and Vaccine Related to Streptococcus pneumoniae" Critical Reviews in Microbiology 18(2): 89-114 (1991).
Lees, A. et al., "Enhanced Immunogenicity of Protein-Dextran Conjugates: I. Rapid Stimulation of Enhanced Antibody Responses to Poorly Immunogenic Molecules" Vaccines 12: 1160-1166 (1994).
Lindberg, B. et al., "Structural Studies on the Specific Type-14 Pneumococcal Polysaccharide" Carbohydrate Research 58: 177-186 (1977).
Lindberg, B. et al., "Structural Studies of the Capsular Polysaccharide from Streptococcus pneumoniae Type 1" Carbohydrate Research 78: 111-117 (1980).
Lock, R. A. et al., "Comparative Efficacy of Autolysin and Pneumolysin as Immunogens Protecting Mice Against
Alberta Research Council
Housel James C.
Shaver Jennifer
LandOfFree
Immunostimulating activity of Streptococcus pneumoniae serotype does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunostimulating activity of Streptococcus pneumoniae serotype , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunostimulating activity of Streptococcus pneumoniae serotype will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1605611